Mental health status may fundamentally alter how the body responds to COVID-19
A large-scale study from UC San Francisco has quietly expanded our understanding of who remains vulnerable in a vaccinated world, finding that people living with psychiatric disorders face meaningfully higher odds of breakthrough COVID-19 infection — even after completing their vaccine series. The research, drawing on nearly 264,000 patients, places mental health alongside cancer and heart disease as a genuine medical risk factor, not a peripheral one. In doing so, it asks a deeper question about how the mind and body together shape immunity, and whether public health strategies have been attentive enough to those already carrying the heaviest burdens.
- Despite full vaccination, people with psychiatric disorders were still contracting COVID-19 at elevated rates — up to 24% higher than vaccinated peers without such diagnoses.
- The risk was not uniform: older adults with substance abuse or psychotic disorders faced the steepest disparities, suggesting age compounds psychiatric vulnerability in ways not yet fully understood.
- Researchers identified two likely culprits — a blunted immune response to vaccines in psychiatric patients, and the increased exposure risk that comes with frequent in-person clinical care.
- The psychiatric risk range of 3–24% placed mental health conditions squarely alongside serious physical illnesses like cancer and kidney disease in terms of breakthrough infection likelihood.
- Study authors are now calling for psychiatric patients to be prioritized for boosters, more frequent screening, and public health outreach tailored to their specific circumstances.
A study of nearly 264,000 vaccinated patients from UC San Francisco and the San Francisco VA Health Care System has found that people with psychiatric disorders face a measurably higher risk of breakthrough COVID-19 infections. Published in JAMA Network Open, the research revealed a baseline 3 percent increased risk across the full cohort — but the disparities grew sharper when broken down by age.
Among adults over 65, the gaps were striking. Those with substance abuse disorders faced a 24 percent higher breakthrough risk compared to vaccinated peers without psychiatric histories. Psychotic disorders carried a 23 percent increase, bipolar disorder 16 percent, and anxiety conditions 12 percent. Younger adults showed smaller but still notable elevations, with substance abuse disorders again leading at 11 percent.
The researchers were careful to note that these figures were comparable to the breakthrough risks associated with serious physical conditions like cancer and cardiovascular disease — a comparison that reframes mental health as a genuine medical risk factor rather than a secondary concern.
Lead author Kristen Nishimi pointed to two possible explanations: some psychiatric conditions may weaken the immune response to vaccination, an effect likely more pronounced in older adults, and certain disorders are associated with behaviors or care routines — like frequent in-person clinical visits — that increase exposure. Senior author Aoife O'Donovan added that vaccine-induced immunity may wane faster or more severely in this population, or offer less protection against emerging variants.
The study's authors recommended prioritizing psychiatric patients for booster doses, more frequent screening, and targeted public health outreach — and called for mental health to be folded into routine clinical conversations about COVID-19 risk. Their findings suggest that a uniform vaccination strategy may be leaving some of the most vulnerable people inadequately protected.
A study of nearly 264,000 vaccinated patients has found that people living with psychiatric disorders face a measurably higher risk of breakthrough COVID-19 infections, even after completing their vaccine regimen. Researchers from UC San Francisco and the San Francisco VA Health Care System analyzed data from patients who had received their full vaccine series and undergone at least one test for the virus. The findings, published in JAMA Network Open, suggest that mental health conditions warrant consideration as a distinct risk factor in pandemic prevention strategies.
More than half the study population—51.4 percent—had received a psychiatric diagnosis within the previous five years. Nearly 15 percent of all participants experienced a breakthrough infection. When the researchers compared vaccinated people with psychiatric histories to those without, they found a baseline 3 percent increased risk of breakthrough infection across the entire cohort. But the picture grew more complex when they separated the data by age.
For people over 65, the disparities widened considerably. Those with substance abuse disorders faced a 24 percent higher risk of breakthrough infection compared to their peers without psychiatric conditions. Psychotic disorders carried a 23 percent increased risk. Bipolar disorder raised the likelihood by 16 percent, adjustment disorders by 14 percent, and anxiety conditions by 12 percent. The pattern held for younger adults too, though with smaller margins: those under 65 with psychiatric diagnoses showed up to an 11 percent elevated risk, with substance abuse disorders again leading at 11 percent, followed by adjustment disorders at 9 percent, and anxiety and post-traumatic stress disorder at 4 and 3 percent respectively.
The researchers noted that these psychiatric-linked increases—ranging from 3 to 16 percent—were comparable to the breakthrough infection risks associated with serious physical conditions like cancer, cardiovascular disease, and kidney disease, which ranged from 7 to 23 percent. This comparison underscores that mental health status appears to function as a genuine medical risk factor rather than a peripheral concern.
Kristen Nishimi, the study's lead author from UCSF's Weill Institute for Neurosciences, offered several explanations for the pattern. Some psychiatric disorders may dampen the immune system's response to vaccination, an effect that could be more pronounced in older adults. Certain conditions are also associated with behavioral patterns that increase exposure risk. Additionally, older adults receiving psychiatric treatment often have frequent in-person clinical appointments, which could translate to greater contact with healthcare settings and potentially higher exposure to the virus.
Aoife O'Donovan, the study's senior author, emphasized that the elevated infection rates could not be attributed solely to demographic factors or existing medical conditions. She suggested that vaccine-induced immunity might wane more rapidly or more severely in people with psychiatric disorders, or that these individuals may have less protection against emerging variants. The findings point toward a possibility that has received limited attention: mental health status may fundamentally alter how the body responds to and maintains protection from COVID-19.
The researchers recommended that people with psychiatric disorders be prioritized for booster vaccinations and other preventive measures, including more frequent screening and targeted public health outreach. They also suggested that mental health should be integrated into clinical discussions about COVID-19 risk and prevention. The study implies that a one-size-fits-all vaccination strategy may miss important vulnerabilities in populations already managing significant health challenges.
Citas Notables
Individuals with psychiatric disorders may be a high-risk group for COVID-19 and should be prioritized for booster vaccinations and other critical preventive efforts.— UCSF researchers, published study
Increased breakthrough infections in people with psychiatric disorders cannot be entirely explained by socio-demographic factors or pre-existing conditions.— Aoife O'Donovan, UCSF Weill Institute for Neurosciences
La Conversación del Hearth Otra perspectiva de la historia
Why would a psychiatric diagnosis change how someone's immune system responds to a vaccine?
That's the question the researchers couldn't fully answer. They found the pattern clearly, but the mechanism isn't settled. Some psychiatric conditions do seem to affect immune function directly. Others might work through behavior—someone with depression might be less likely to maintain isolation practices, or someone with substance abuse issues faces different exposure patterns. It's probably both.
The numbers are striking for older adults. A 24 percent increase for substance abuse seems enormous.
It is. And it's worth noting that older adults were hit harder across the board. The researchers think the immune system's ability to respond to vaccination weakens with age generally, and psychiatric conditions may compound that. An 80-year-old with a psychotic disorder faces a different biological reality than a 35-year-old with the same diagnosis.
Did the study explain why anxiety disorders showed smaller increases than substance abuse?
Not explicitly. But you can infer something: substance abuse disorders involve direct physiological stress on the body—liver damage, inflammation, immune suppression. Anxiety is real and serious, but it might work through different pathways. The researchers hint that behavioral factors matter too, and substance abuse carries obvious exposure risks.
If psychiatric patients are a high-risk group, why hasn't this been front and center in public health messaging?
That's a fair question the study raises implicitly. Mental health has been somewhat siloed from pandemic response planning. This research suggests it shouldn't be. These aren't small numbers—over half the study population had some psychiatric diagnosis. If you're not thinking about mental health when you're designing booster campaigns, you're missing a significant vulnerable population.
The comparison to physical diseases is interesting. Does that change how we should think about this?
It reframes the conversation. Mental health conditions are often treated as secondary concerns, things that complicate treatment but aren't primary medical risks. This study suggests psychiatric status belongs in the same risk-stratification conversation as cancer or heart disease. That's a meaningful shift in how medicine should approach these patients.